NP Life Sciences Health Industry Group Inc. (ACAT) Operating income 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) annual operating income history from SEC filings — each fiscal year as reported.
-$690FY2023 · since FY2019: -$108,859 → -$690
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$690 | +96.3% |
| FY2022 | -$18,855 | +71.3% |
| FY2021 | -$65,681 | +49.9% |
| FY2020 | -$131,091 | -20.4% |
| FY2019 | -$108,859 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAT financial trends
ACAT RevenueACAT Net incomeACAT Net marginACAT Gross profitACAT Gross marginACAT Operating marginACAT Operating cash flowACAT Free cash flowACAT Capital expendituresACAT Return on equityACAT Stock buybacksACAT Dividends paidACAT Total assetsACAT Total liabilitiesACAT Shareholders’ equityACAT overview →